{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:01:57Z","timestamp":1778126517744,"version":"3.51.4"},"reference-count":62,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            A variety of innate defense factors in saliva such as lysozyme and lactoferrin contribute to mucosal protection and modulate\n            <jats:italic>Candida<\/jats:italic>\n            populations in the oral cavity. It is also known that in human immunodeficiency virus (HIV)-infected individuals significant variations in the concentrations of lysozyme and lactoferrin in saliva occur during disease progression. Therefore, the aim of this study was to determine the in vitro susceptibility to human lactoferrin and hen egg white lysozyme of genotypically similar oral\n            <jats:italic>Candida albicans<\/jats:italic>\n            isolates obtained from six HIV-infected ethnic Chinese during sequential visits over a 12-month period. The similarity of the genotypes (50 in total) was evaluated using a randomly amplified polymorphic DNA assay. A blastospore viability assay was performed to evaluate the sensitivity of the organisms to lysozyme and lactoferrin. Exposure to physiological concentrations of either lysozyme (30 \u03bcg\/ml) or lactoferrin (20 \u03bcg\/ml) caused a rapid loss of viability among all isolates to a varying extent. None of the sequential\n            <jats:italic>C<\/jats:italic>\n            .\n            <jats:italic>albicans<\/jats:italic>\n            isolates demonstrated significant differences in sensitivity to either protein from one visit to the next; similar results were noted when the different genotypes from the same individual were compared. On Spearman correlation analysis of two genotypes that were sequentially isolated from a single patient, a significant negative correlation between lysozyme (\n            <jats:italic>r<\/jats:italic>\n            = \u22120.88;\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.02) (but not lactoferrin) resistance and the duration of HIV disease was seen. These results imply that a minority of\n            <jats:italic>C<\/jats:italic>\n            .\n            <jats:italic>albicans<\/jats:italic>\n            isolates that persist intraorally in individuals with HIV disease develop progressive resistance to innate salivary antifungal defenses such as lysozyme, possibly as an adaptive response. However, the vast majority of the\n            <jats:italic>Candida<\/jats:italic>\n            isolates appear to succumb to these nonspecific host immune mediators abundantly present in the oral environment.\n          <\/jats:p>","DOI":"10.1128\/jcm.39.9.3296-3302.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:03:40Z","timestamp":1027764220000},"page":"3296-3302","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":87,"title":["Antifungal Effects of Lysozyme and Lactoferrin against Genetically Similar, Sequential\n            <i>Candida albicans<\/i>\n            Isolates from a Human Immunodeficiency Virus-Infected Southern Chinese Cohort"],"prefix":"10.1128","volume":"39","author":[{"given":"Y. H.","family":"Samaranayake","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Oral Bio-Sciences1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. P.","family":"Samaranayake","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Oral Bio-Sciences1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. H. N.","family":"Pow","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Oral Rehabilitation,2 Faculty of Dentistry, University of Hong Kong, Hong Kong Special Administrative Region, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. T.","family":"Beena","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Oral Bio-Sciences1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. W. S.","family":"Yeung","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Oral Bio-Sciences1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199754050-00002"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1989.tb01344.x"},{"key":"e_1_3_1_4_2","first-page":"41","article-title":"Elevation of salivary antimicrobial proteins following HIV-1 infection","volume":"3","author":"Atkinson J. C.","year":"1990","unstructured":"Atkinson J. C. Yeh C.-K. Oppenheim F. G. Bermudez D. Baum B. J. Fox P. C. Elevation of salivary antimicrobial proteins following HIV-1 infection.J. Acquir. Immune Defic. Syndr.319904148","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.131.3.559"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.11.2933-2937.1993"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-139-9-2179"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.43.3.966-972.1984"},{"key":"e_1_3_1_9_2","unstructured":"Cole\nM. F.\nArnold\nR.\nMestecky\nJ.\nKulhavy\nR.\nMcGhee\nJ. R.\nStudies with human lactoferrin and Streptococcus mutans Microbial aspects of dental caries II\u20141976.\nStiles\nH.\nLoesche\nW.\nO'Brien\nT.\n1976\n274\n359\nInformation Retrieval\nWashington D.C."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.31.3.998-1002.1981"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/00220345800590090101"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-136-7-1437"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1991.0331"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02308-2"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02051947"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01552309"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.48.3.720-728.1985"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.10.3783"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/00220345870660021601"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.12.3249-3254.1992"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1988.tb00408.x"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.6.2219-2226.2000"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2516(07)80042-2"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1992.tb00103.x"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(85)90258-0"},{"key":"e_1_3_1_26_2","first-page":"627","article-title":"Fungitoxicity of muramidase, ultrastructural damage to Candida albicans","volume":"46","author":"Marquis G.","year":"1982","unstructured":"Marquis G. Montplaisir S. Garzon S. Strykowski H. Auger P. Fungitoxicity of muramidase, ultrastructural damage to Candida albicans.Lab. Investig.461982627636","journal-title":"Lab. Investig."},{"key":"e_1_3_1_27_2","first-page":"115","article-title":"Studies of lactoferrin, the iron binding protein of secretions","volume":"14","author":"Massons P.","year":"1966","unstructured":"Massons P. Heremans J. Studies of lactoferrin, the iron binding protein of secretions.Protides Biol. Fluids141966115124","journal-title":"Protides Biol. Fluids"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.130.3.643"},{"key":"e_1_3_1_29_2","first-page":"643","article-title":"Comparative studies of the iron-binding properties of human transferrins","volume":"718","author":"Mazurier J.","year":"1980","unstructured":"Mazurier J. Spik G. Comparative studies of the iron-binding properties of human transferrins.Biochim. Biophys. Acta7181980643658","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1834-7819.1995.tb03122.x"},{"key":"e_1_3_1_31_2","first-page":"46","article-title":"Nonspecific oral immunity in individuals with HIV infection","volume":"5","author":"Muller F.","year":"1992","unstructured":"Muller F. Holberg-Petersen M. Rollag H. Degre M. Brandtzaeg P. Froland S. S. Nonspecific oral immunity in individuals with HIV infection.J. Acquir. Immune Defic. Syndr.519924651","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(94)90026-4"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(93)90167-K"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.8.1923-1929.1994"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.1.59-64.1994"},{"key":"e_1_3_1_36_2","first-page":"418","article-title":"Lysozyme activity and flow rates of mixed saliva in children, adolescents and adults","volume":"84","author":"Raeste A. M.","year":"1976","unstructured":"Raeste A. M. Touompo A. Lysozyme activity and flow rates of mixed saliva in children, adolescents and adults.Scand. J. Dent. Res.841976418422","journal-title":"Scand. J. Dent. Res."},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.7.1761-1765.1997"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(85)90129-3"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90191-R"},{"key":"e_1_3_1_40_2","unstructured":"Samaranayake\nL. P.\nMacFarlane\nT. W.\nOral candidosis.\n1990\nWright-Butterworth\nLondon United Kingdom"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1986.tb00646.x"},{"key":"e_1_3_1_42_2","first-page":"23","article-title":"The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media","volume":"74","author":"Samaranayake Y. H.","year":"1993","unstructured":"Samaranayake Y. H. MacFarlane T. W. Samaranayake L. P. Aitchison T. C. The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media.Microbios7419932328","journal-title":"Microbios"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.1993.tb00662.x"},{"key":"e_1_3_1_44_2","unstructured":"Samaranayake Y. H. L. P. Samaranayake P. C. Tsang K. H. Wong and K. W. S. Yeung. J. Oral Pathol. Med. in press."},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1997.tb05097.x"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90300-X"},{"key":"e_1_3_1_47_2","first-page":"26","article-title":"Sialochemistry in human immunodeficiency virus associated salivary gland disease","volume":"19","author":"Schiodt M.","year":"1992","unstructured":"Schiodt M. Atkinson J. C. Greenspan D. Fox P. C. Dodd C. L. Daniels T. E. Greenspan J. S. Sialochemistry in human immunodeficiency virus associated salivary gland disease.J. Rheumatol.1919922629","journal-title":"J. Rheumatol."},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.4.935-941.1992"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.11.2646-2654.1994"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.27.4.681-690.1989"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1992.tb05156.x"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.8.2031-2039.1997"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1177\/00220345830620050701"},{"key":"e_1_3_1_54_2","first-page":"55","article-title":"Nonimmunoglobulin defense factors in human saliva","author":"Tenovuo J.","year":"1989","unstructured":"Tenovuo J. Nonimmunoglobulin defense factors in human saliva Human saliva: clinical chemistry and microbiology Tenovuo J. II 1989 55 91 CRC Press, Inc. Boca Raton, Fla","journal-title":"Human saliva: clinical chemistry and microbiology"},{"key":"e_1_3_1_55_2","first-page":"197","article-title":"Salivary lysozyme, lactoferrin and peroxidases. Antibacterial effect on cariogenic bacteria and clinical application in preventive dentistry","volume":"87","author":"Tenovuo J.","year":"1991","unstructured":"Tenovuo J. Lumikari M. Soukka T. Salivary lysozyme, lactoferrin and peroxidases. Antibacterial effect on cariogenic bacteria and clinical application in preventive dentistry.Proc. Finn. Dent. Soc.871991197208","journal-title":"Proc. Finn. Dent. Soc."},{"key":"e_1_3_1_56_2","first-page":"1","article-title":"The in vitro susceptibility of Candida species to lysozyme","volume":"2","author":"Tobgi R. S.","year":"1988","unstructured":"Tobgi R. S. Samaranayake L. P. MacFarlane T. W. The in vitro susceptibility of Candida species to lysozyme.Oral Microbiol. Immunol.2198814","journal-title":"Oral Microbiol. Immunol."},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1999.tb00308.x"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.1999.12.197"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-302x.2001.016002106.x"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.42.1.45-66.1978"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.2.513"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1080\/02681219980000051"},{"key":"e_1_3_1_63_2","first-page":"361","article-title":"Oral defense mechanisms are impaired early in HIV-1 infected patients","volume":"1","author":"Yeh C.-K.","year":"1988","unstructured":"Yeh C.-K. Fox P. C. Ship J. A. Busch K. A. Bermudez D. K. Wilder A.-M. Katz R. W. Wolff A. Tylenda C. A. Atkinson J. C. Baum B. J. Oral defense mechanisms are impaired early in HIV-1 infected patients.J. Acquir. Immune Defic. Syndr.11988361366","journal-title":"J. Acquir. Immune Defic. Syndr."}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.9.3296-3302.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.9.3296-3302.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T01:20:47Z","timestamp":1646443247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.39.9.3296-3302.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1128\/JCM.39.9.3296-3302.2001"],"URL":"https:\/\/doi.org\/10.1128\/jcm.39.9.3296-3302.2001","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]},"assertion":[{"value":"2001-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-07-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}